Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral efficacy, safety and tolerability of
dual therapy with 3TC and DTG as initial therapy among naïve HIV patients